IBDEI0TI ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14285,0)
 ;;=20500^^75^882^10^^^^1
 ;;^UTILITY(U,$J,358.3,14285,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14285,1,2,0)
 ;;=2^Injection of sinus tract; therapeutic diagnostic
 ;;^UTILITY(U,$J,358.3,14285,1,3,0)
 ;;=3^20500
 ;;^UTILITY(U,$J,358.3,14286,0)
 ;;=96402^^75^882^9^^^^1
 ;;^UTILITY(U,$J,358.3,14286,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14286,1,2,0)
 ;;=2^Injec,IM,anti-neplastic horm
 ;;^UTILITY(U,$J,358.3,14286,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,14287,0)
 ;;=64450^^75^882^12^^^^1
 ;;^UTILITY(U,$J,358.3,14287,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14287,1,2,0)
 ;;=2^Injection, Nerve Block
 ;;^UTILITY(U,$J,358.3,14287,1,3,0)
 ;;=3^64450
 ;;^UTILITY(U,$J,358.3,14288,0)
 ;;=96360^^75^882^7^^^^1
 ;;^UTILITY(U,$J,358.3,14288,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14288,1,2,0)
 ;;=2^Hydration IV Inf,31-60 min
 ;;^UTILITY(U,$J,358.3,14288,1,3,0)
 ;;=3^96360
 ;;^UTILITY(U,$J,358.3,14289,0)
 ;;=96361^^75^882^8^^^^1
 ;;^UTILITY(U,$J,358.3,14289,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14289,1,2,0)
 ;;=2^Hydration IV Infus,Ea Add Hr
 ;;^UTILITY(U,$J,358.3,14289,1,3,0)
 ;;=3^96361
 ;;^UTILITY(U,$J,358.3,14290,0)
 ;;=96365^^75^882^18^^^^1
 ;;^UTILITY(U,$J,358.3,14290,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14290,1,2,0)
 ;;=2^Ther/Proph/Diag IV Inf,Init Hr
 ;;^UTILITY(U,$J,358.3,14290,1,3,0)
 ;;=3^96365
 ;;^UTILITY(U,$J,358.3,14291,0)
 ;;=96366^^75^882^17^^^^1
 ;;^UTILITY(U,$J,358.3,14291,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14291,1,2,0)
 ;;=2^Ther/Proph/Diag IV Inf,Ea Add Hr
 ;;^UTILITY(U,$J,358.3,14291,1,3,0)
 ;;=3^96366
 ;;^UTILITY(U,$J,358.3,14292,0)
 ;;=96372^^75^882^19^^^^1
 ;;^UTILITY(U,$J,358.3,14292,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14292,1,2,0)
 ;;=2^Ther/Proph/Diag Inj, SC/IM
 ;;^UTILITY(U,$J,358.3,14292,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,14293,0)
 ;;=20501^^75^882^11^^^^1
 ;;^UTILITY(U,$J,358.3,14293,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14293,1,2,0)
 ;;=2^Injection of sinus tract;diagnostic
 ;;^UTILITY(U,$J,358.3,14293,1,3,0)
 ;;=3^20501
 ;;^UTILITY(U,$J,358.3,14294,0)
 ;;=20604^^75^882^4^^^^1
 ;;^UTILITY(U,$J,358.3,14294,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14294,1,2,0)
 ;;=2^Arthroc,Aspir/Inj Sm Joint/Bursa,US,Rec/Rpt
 ;;^UTILITY(U,$J,358.3,14294,1,3,0)
 ;;=3^20604
 ;;^UTILITY(U,$J,358.3,14295,0)
 ;;=20606^^75^882^2^^^^1
 ;;^UTILITY(U,$J,358.3,14295,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14295,1,2,0)
 ;;=2^Arthroc,Aspir/Inj Joint/Bursa,US,Rec/Rpt
 ;;^UTILITY(U,$J,358.3,14295,1,3,0)
 ;;=3^20606
 ;;^UTILITY(U,$J,358.3,14296,0)
 ;;=20612^^75^882^5^^^^1
 ;;^UTILITY(U,$J,358.3,14296,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14296,1,2,0)
 ;;=2^Aspirate/Inj Ganglion Cyst
 ;;^UTILITY(U,$J,358.3,14296,1,3,0)
 ;;=3^20612
 ;;^UTILITY(U,$J,358.3,14297,0)
 ;;=J0690^^75^883^2^^^^1
 ;;^UTILITY(U,$J,358.3,14297,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14297,1,2,0)
 ;;=2^Cefazolin Sodium Inj 500mg
 ;;^UTILITY(U,$J,358.3,14297,1,3,0)
 ;;=3^J0690
 ;;^UTILITY(U,$J,358.3,14298,0)
 ;;=S0077^^75^883^3^^^^1
 ;;^UTILITY(U,$J,358.3,14298,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14298,1,2,0)
 ;;=2^Clindamycin Phosphate Inj 300mg
 ;;^UTILITY(U,$J,358.3,14298,1,3,0)
 ;;=3^S0077
 ;;^UTILITY(U,$J,358.3,14299,0)
 ;;=J3360^^75^883^5^^^^1
 ;;^UTILITY(U,$J,358.3,14299,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,14299,1,2,0)
 ;;=2^Diazepam up to 5mg
 ;;^UTILITY(U,$J,358.3,14299,1,3,0)
 ;;=3^J3360
 ;;^UTILITY(U,$J,358.3,14300,0)
 ;;=J1710^^75^883^6^^^^1
 ;;^UTILITY(U,$J,358.3,14300,1,0)
 ;;=^358.31IA^3^2
 ;;
 ;;$END ROU IBDEI0TI
